# Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19

> **NCT04323228** · PHASE2,PHASE3 · UNKNOWN · sponsor: **King Saud University** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** Oral supplement enriched in antioxidants
- **DIETARY_SUPPLEMENT:** cellulose-containing placebo capsules

## Key facts

- **NCT ID:** NCT04323228
- **Lead sponsor:** King Saud University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04323228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04323228, "Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04323228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*